Skip to main content

Year: 2021

Victoria’s Secret & Co. Announces $250 Million Accelerated Share Repurchase Program

Company Reaffirms Fourth Quarter Sales, Operating Income And Earnings Guidance REYNOLDSBURG, Ohio, Dec. 29, 2021 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today announced that it has entered into an accelerated share repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $250 million of the Company’s common stock. The Company also reaffirmed fourth quarter sales, operating income and earnings guidance. Under the ASR, the Company will make an initial payment of $250 million to Goldman Sachs and will receive an initial delivery of approximately 4.1 million shares of the Company’s common stock on December 31, 2021. The final number of shares to be repurchased will be based on the volume-weighted average price of the Company’s common stock...

Continue reading

Collective Mining Reviews 2021 Achievements and Announces Plans for 2022

Figure 1Plan View of the 3.5 km x 3 km Porphyry Cluster Outlined at the Guayabales ProjectFigure 2Plan View of the 1.3 km Long Pound Target at the San Antonio ProjectTORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Collective Mining Ltd. (TSXV: CNL) (“Collective” or the “Company”) is pleased to review its accomplishments of 2021 and outline its business plan for 2022 for its Guayabales and San Antonio projects. The properties are located in Caldas Colombia and the Company has the right to earn 100% unencumbered interests in both projects. 2021 Highlights Guayabales Project (Figure 1)4,838 metres of diamond drilling has been completed at the project as of December 22, 2021.Due to the operating team’s extensive Colombian experience, the Company was able to rapidly advance surface exploration at Guayabales,...

Continue reading

CurrencyWorks Announces US$500,000 Strategic Financing Led By Management

Los Angeles, CA, Dec. 29, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a blockchain pioneer, NFT, and digital payment provider, today announced that the Company intends to complete a non-brokered private placement pursuant to Section 4(a)(2) of the Securities Act of 1933 or Regulation S under the Securities Act of 1933, as applicable, pursuant to which the Company plans to sell to Jimmy Geiskopf, Cameron Chell and Swapan Kakumanu, directors and executive officers of the Company, shares of common stock for gross proceeds of US$50,000 of the Company. These shares are to be priced at the market as of the market close (OTCQB) on Tuesday, December 28, 2021 with no discount, no warrant and will be subject a hold period under United States securities laws and, if applicable,...

Continue reading

Consolidated Uranium Provides Update to Shareholders

TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (the “Company”, “CUR” or “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) is pleased to share an open letter from Chairman and Chief Executive Officer, Philip Williams, to shareholders of the Company. Dear Fellow Shareholders: As we end 2021, I wanted to take a moment to reflect on our Company’s achievements over the past year and set out our objectives for the upcoming year and beyond. Continued Uranium Market Resurgence Looking back at our letter from last year, we noted that uranium prices had increased from the low of US$20.00 per lb in early 2020 to close that year at approximately US$30.00 per lb. At that time, we expected prices, both spot and long term, to continue to climb and we were not disappointed. As of writing this letter, according...

Continue reading

Digital Ally Announces Year-End Patent Review

Digital Ally totals eight issued patents for 2021, further bolstering its patent portfolio Lenexa, KS, Dec. 29, 2021 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), today announced its 2021 year-end patent review. These issued patents demonstrate the Company’s commitment to engineering innovative evidence capturing and safety technology for law enforcement, first responders and commercial fleets. In addition to the two patents released during the first quarter of 2021 – U.S. Patent numbers 10,904,474 & 10,885,937 – the USPTO has issued Digital Ally six further patents, bringing its total to eight issued patents during the 2021 calendar year. “We are extremely proud of the hard-work and dedication our engineering team has put in, in order to strengthen our existing patent portfolio,” said Stan Ross,...

Continue reading

Aptose to Participate in Two Biotech Events in January 2022

— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event — SAN DIEGO and TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS) today announced that the company will participate in two separate biotech events in January 2022: the H.C. Wainwright BIOCONNECT Virtual Conference and the 11th Annual LifeSci Partners Corporate Access Event. The Aptose management team will be hosting investor meetings during both events. Details of the events are as follows:Event:     H.C. Wainwright BIOCONNECT Virtual ConferenceDate:     January 10-13, 2022Time:     Presentations available starting at 7:00 a.m., ET on January 10, 2022Webcast:     Accessible for registered conference attendees via the conference’s virtual platform.       Event:     11th...

Continue reading

Zai Lab Announces Upcoming Presentations at January Investor Conferences

SHANGHAI, SAN FRANCISCO and CAMBRIDGE, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following virtual investor conferences in January: 40th Annual J.P. Morgan Healthcare ConferencePresentation: Monday, January 10, 2022, 9:00 a.m. ET BofA 2022 New York Asia DayPresentation: Tuesday, January 18, 2022, 9:00 a.m. ET Webcast link of the 40th Annual J.P. Morgan Healthcare Conference will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 30 days following the event. About Zai Lab Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage,...

Continue reading

Aehr Test Systems to Present at 24th Annual Needham Virtual Growth Conference on January 12, 2022

FREMONT, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that President and CEO Gayn Erickson and CFO Ken Spink will present at the 24th Annual Needham Virtual Growth Conference on Wednesday, January 12 at 2:45pm ET (11:45am PT), and will participate in virtual one-on-one meetings with investors throughout the day. “We look forward to discussing our semiconductor wafer level and singulated die test and burn-in solutions and the markets they serve with investors,” said Mr. Erickson. “Aehr Test provides complete production solutions for improving yield and reliability of semiconductors, and devices such as silicon carbide semiconductors used in electric and hybrid electric vehicles, silicon photonics devices...

Continue reading

Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibilityTORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million (the “Credit Facility”). “This financing improves our liquidity and capital structure as the Company’s senior secured debt obligations will now mature in December 2023 rather than in August 2022,” said Aleafia Health CEO Geoffrey Benic. “The transaction allows us to continue the growth of our core adult-use and medical cannabis sales channels, as we again expect to realize sequential growth in both channels over the previous quarter.” The Credit Facility is financed by the Garrington...

Continue reading

Valoe’s Financial Information and Annual General Meeting in 2022

Valoe Corporation         Stock Exchange Release         29 December 2021 at 14.30 Finnish time In 2022, Valoe Corporation (“Company”) will publish a financial statements release, an annual report, a half-year financial report, and two business reviews as follows:Financial statements release 2021 on Wednesday 23 February 2022 Business review for January-March 2022 on Tuesday 24 May 2022 Half-year report for January-June 2022 on Wednesday 24 August 2022 Business review for January-September 2022 on Wednesday 16 November 2022The Annual Report 2021 will be published on the company’s home page during the week 17/2022 at the latest. Valoe Corporation’s Annual General Meeting will be held on Wednesday 25 May 2022. In Mikkeli 29 December 2021 Valoe Corporation Board of Directors For more information:Iikka Savisalo, President and CEO,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.